MICROPORT CARDIO.MEDTECH. - Asset Resilience Ratio

Latest as of June 2025: 37.03%

MICROPORT CARDIO.MEDTECH. (72X) has an Asset Resilience Ratio of 37.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€987.89 Million
≈ $1.15 Billion USD Cash + Short-term Investments

Total Assets

€2.67 Billion
≈ $3.12 Billion USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how MICROPORT CARDIO.MEDTECH.'s Asset Resilience Ratio has changed over time. See MICROPORT CARDIO.MEDTECH. (72X) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down MICROPORT CARDIO.MEDTECH.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 72X market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €987.89 Million 37.03%
Total Liquid Assets €987.89 Million 37.03%

Asset Resilience Insights

  • Very High Liquidity: MICROPORT CARDIO.MEDTECH. maintains exceptional liquid asset reserves at 37.03% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

MICROPORT CARDIO.MEDTECH. Industry Peers by Asset Resilience Ratio

Compare MICROPORT CARDIO.MEDTECH.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Bactiguard Holding AB (publ)
ST:BACTI-B
Medical Devices 8.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%

Annual Asset Resilience Ratio for MICROPORT CARDIO.MEDTECH. (2022–2024)

The table below shows the annual Asset Resilience Ratio data for MICROPORT CARDIO.MEDTECH..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 46.74% €1.25 Billion
≈ $1.46 Billion
€2.68 Billion
≈ $3.13 Billion
+19.26pp
2023-12-31 27.48% €708.27 Million
≈ $828.04 Million
€2.58 Billion
≈ $3.01 Billion
+20.52pp
2022-12-31 6.96% €208.94 Million
≈ $244.27 Million
€3.00 Billion
≈ $3.51 Billion
--
pp = percentage points

About MICROPORT CARDIO.MEDTECH.

F:72X Germany Medical Devices
Market Cap
$366.87 Million
€313.80 Million EUR
Market Cap Rank
#18868 Global
#1753 in Germany
Share Price
€0.25
Change (1 day)
-23.80%
52-Week Range
€0.08 - €0.42
All Time High
€2.25
About

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more